Shopping Cart
- Remove All
Your shopping cart is currently empty
Israpafant is a selective antagonist for the platelet-activating factor receptor ( IC50 = 0.84nM). Israpafant inhibits PAF-induced human platelet aggregation. Israpafant inhibits the activation of eosinophil cells and consequently delays the development of immune responses. Israpafant also has anti-nephrotoxic properties and to mobilize calcium transport.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $2,420 | 3-6 months | |
| 50 mg | $3,180 | 3-6 months | |
| 100 mg | $4,300 | 3-6 months |
| Description | Israpafant is a selective antagonist for the platelet-activating factor receptor ( IC50 = 0.84nM). Israpafant inhibits PAF-induced human platelet aggregation. Israpafant inhibits the activation of eosinophil cells and consequently delays the development of immune responses. Israpafant also has anti-nephrotoxic properties and to mobilize calcium transport. |
| Synonyms | Y-24180, Y24180, Y 24180 |
| Molecular Weight | 489.07 |
| Formula | C28H29ClN4S |
| Cas No. | 117279-73-9 |
| Relative Density. | 1.26g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.